FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 107 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $234 | -79.4% | 52,734 | -84.7% | 0.00% | -100.0% |
Q2 2023 | $1,138 | +2.3% | 344,810 | -11.6% | 0.00% | +100.0% |
Q1 2023 | $1,112 | -99.7% | 390,100 | +473.7% | 0.00% | – |
Q2 2022 | $333,000 | -91.2% | 68,000 | -49.2% | 0.00% | -100.0% |
Q3 2021 | $3,777,000 | – | 133,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |